Preparation of hydrated polymorphs of 4-amino-5-fluoro-3-[6-(4methylpiperazin-1-yl)-1H-benzimidazol-2-yl]-1H-quinolin-2-one lactic acid salt

Details for Australian Patent Application No. 2011231546 (hide)

Owner Novartis AG

Inventors Grandeury, Arnaud; Riegert, Christian; Schreiner, Andreas

Agent Davies Collison Cave

Pub. Number AU-A-2011231546

PCT Pub. Number WO2011/117380

Priority 61/317,943 26.03.10 US

Filing date 25 March 2011

Wipo publication date 29 September 2011

International Classifications

C07D 401/04 Heterocyclic compounds containing two or more hetero rings

Event Publications

18 October 2012 PCT application entered the National Phase

  PCT publication WO2011/117380 Priority application(s): WO2011/117380

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2011231557-Novel composition for treatment of essential thrombocythemia

2011231544-Improved methods and compositions for safe and effective treatment of telangiectasia